IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation

Experimental Hematology
Tingchao ChenYi Zhao


Severe myelosuppression is a common side effect of radiotherapy or chemotherapy. Methods have been developed to protect patients by stimulating white blood cell or red blood cell recovery/production using growth factors such as G-CSF or EPO. However, there is no available means to stimulate the full-lineage blood cell recovery from severe myelosuppression. In this study, we used lethally or sublethally irradiated animal models to evaluate the hematopoiesis stimulating effect of IL-12. IL-12-treated lethally or sublethally irradiated animals were examined for the survival/lifespan, the function assays (bone marrow transplantation, CFU-S(12), CFC) of bone marrow cell subsets, and apoptosis assay. Using a low dose of IL-12 (10 times lower than previously reported dose), 91.4% of lethally irradiated animals survived long term without adverse effects on the gastrointestinal (GI) system. The reconstituted hematopoietic system was derived from long-term reconstituting hematopoietic stem cells (LTR HSC), which reconstituted hematopoiesis both endogenously after lethal radiation and in secondary recipients by bone marrow transplantation (BMT). IL-12 significantly attenuated the decline of blood cell counts in sublethally irradiated anim...Continue Reading


Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K M ZseboI K McNiece
Jan 1, 1988·Pharmacology & Therapeutics·R Neta
Apr 19, 1995·Journal of the National Cancer Institute·E E VoestJ Folkman
Aug 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·H J ZehM T Lotze
Jan 1, 1997·Stem Cells·I R Lemischka
Feb 19, 1998·Environmental Health Perspectives·R Neta
Aug 6, 2000·Cell and Tissue Research·M Verheij, H Bartelink
Nov 1, 2001·Annual Review of Cell and Developmental Biology·I L WeissmanF Gage
Mar 20, 2002·Cytokine & Growth Factor Reviews·Mario P Colombo, Giorgio Trinchieri
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Mar 4, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Darrell N KottonAlan Fine
Aug 5, 2003·Journal of Cellular Biochemistry·Melody BaddooDonald G Phinney
Oct 24, 2003·Nature·L M CalviD T Scadden
Jan 1, 1997·Apoptosis : an International Journal on Programmed Cell Death·K D Held
Feb 6, 2004·Blood Cells, Molecules & Diseases·J P ShawP Shamamian
Jun 2, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jiang Zhu, Stephen G Emerson
Jul 17, 2004·Current Opinion in Hematology·Kateri A Moore
Oct 30, 2004·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Gautam MaulikRavi Salgia
Jun 2, 2005·The Journal of Experimental Medicine·Sebastian StierDavid T Scadden

❮ Previous
Next ❯


Feb 5, 2009·Calcified Tissue International·Sophie DesmonsGuillaume Penel
Jul 28, 2013·Fiziologiia cheloveka·E R andreeva, L B Buravkova
Aug 6, 2009·The American Journal of Chinese Medicine·Weihua DongYanjie He
Mar 4, 2014·Journal of Hematology & Oncology·Katarzyna A DarlakEdmund K Waller
Sep 20, 2011·Best Practice & Research. Clinical Haematology·Jarrod A Dudakov, Marcel R M van den Brink
Mar 10, 2011·Basic & Clinical Pharmacology & Toxicology·Chao ZhangBailong Li
Apr 15, 2014·Experimental Hematology & Oncology·Mamata S GokhaleLena A Basile
Dec 24, 2011·International Journal of Radiation Biology·Vijay K SinghMark H Whitnall
Dec 22, 2009·Expert Opinion on Therapeutic Patents·Francis DumontPierre Bischoff
Oct 16, 2014·Expert Opinion on Therapeutic Patents·Vijay K SinghThomas M Seed
Apr 19, 2016·Immunological Reviews·Mohammed S ChaudhryMarcel R M van den Brink
Feb 6, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jiusheng DengJacques Galipeau
Jul 6, 2014·Radiology and Oncology·Zhitong BingLei Yang
Feb 26, 2008·FEBS Letters·Eunjin ParkYoungheun Jee
Oct 25, 2020·Nature Reviews. Immunology·Enrico VelardiMarcel R M van den Brink
Feb 21, 2021·Seminars in Immunopathology·David GranadierJarrod A Dudakov
Sep 15, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Y DuanY Qin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.